Page 169 - Haematologica May 2020

Acute Lymphoblastic Leukemia
Impact of cytogenetic abnormalities on outcomes of adult Philadelphia-negative
acute lymphoblastic leukemia after allogeneic hematopoietic stem cell transplantation:
a study by the Acute Leukemia Working Committee of the Center for International Blood and Marrow Transplant Research
Ferrata Storti Foundation
Haematologica 2020 Aleksandr Lazaryan, Michelle Dolan, Mei-Jie Zhang, Hai-Lin Wang, Mohamed Volume 105(5):1329-1338
1 2 3,4 3
A. Kharfan-Dabaja,5 David I. Marks,6 Nelli Bejanyan,7 Edward Copelan,8 Navneet S. Majhail,9 Edmund K. Waller,10 Nelson Chao,11 Tim Prestidge,12 Taiga Nishihori,13 Partow Kebriaei,14 Yoshihiro Inamoto,15 Betty Hamilton,16 Shahrukh K. Hashmi,17, 18 Rammurti T. Kamble,19 Ulrike Bacher,20 Gerhard C. Hildebrandt,21 Patrick J. Stiff,22 Joseph McGuirk,23 Ibrahim Aldoss,24 Amer M. Beitinjaneh,25 Lori Muffly,26 Ravi Vij,27 Richard F. Olsson28, 29, Michael Byrne,30 Kirk R. Schultz,31 Mahmoud Aljurf,18 Matthew Seftel,32 Mary Lynn Savoie,33 Bipin N. Savani,34 Leo F. Verdonck,35 Mitchell S. Cairo,36 Nasheed Hossain,37 Vijaya Raj Bhatt,38 Haydar A. Frangoul,39 Hisham Abdel-Azim,40 Monzr Al Malki,24 Reinhold Munker,41 David Rizzieri,42 Nandita Khera,43 Ryotaro Nakamura,44 Olle Ringdén,45 Marjolein van der Poel,46 Hemant S. Murthy,47 Hongtao Liu,48 Shahram Mori,49 Satiro De Oliveira,50 Javier Bolaños- Meade,51 Mahmoud Elsawy,52 Pere Barba,53 Sunita Nathan,54 Biju George,55 Attaphol Pawarode,56 Michael Grunwald,57 Vaibhav Agrawal,58 Youjin Wang,59 Amer Assal,60 Paul Castillo Caro,61 Yachiyo Kuwatsuka,62 Sachiko Seo, 63Celalettin Ustun,64 Ioannis Politikos,65 Hillard M. Lazarus,66 Wael Saber,3 Brenda M. Sandmaier,67 Marcos De Lima,68 Mark Litzow,69 Veronika Bachanova70 and Daniel Weisdorf,71 Acute Leukemia Committee of the CIBMTR3
1H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA; 2University of Minnesota Medical Center, Minneapolis, MN, USA; 3CIBMTR (Center for International Blood and Marrow Transplant Research), Department of Medicine, Medical College of Wisconsin, Milwaukee, WI, USA; 4Division of Biostatistics, Institute for Health and Equity, Medical College of Wisconsin, Milwaukee, WI, USA; 5Division of Hematology-Oncology, Blood and Marrow Transplantation Program, Mayo Clinic, Jacksonville, FL, USA; 6Adult Bone Marrow Transplant, University Hospitals Bristol NHS Trust, Bristol, UK; 7Department of Blood and Marrow Transplant and Cellular Immunotherapy, Moffitt Cancer Center, Tampa, FL, USA; 8Levine Cancer Institute, Atrium Health, Carolinas HealthCare System, Charlotte, NC, USA; 9Blood & Marrow Transplant Program, Cleveland Clinic Taussig Cancer Institute, Cleveland, OH, USA; 10Department of Hematology and Medical Oncology, Winship Cancer Institute, Emory University, Atlanta, GA, USA; 11Division of Cell Therapy and Hematology, Department of Medicine, Duke University Medical Center, Durham, NC, USA; 12Blood and Cancer Centre, Starship Children's Hospital, Auckland, New Zealand; 13Department of Blood and Marrow Transplantation, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA; 14Department of Stem Cell Transplantation, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, TX, USA; 15Division of Hematopoietic Stem Cell Transplantation, National Cancer Center Hospital, Tokyo, Japan; 16Blood & Marrow Transplant Program, Cleveland Clinic Taussig Cancer Institute, Cleveland, OH, USA; 17Department of Internal Medicine, Mayo Clinic, MN, USA; 18Oncology Center, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia; 19Division of Hematology and Oncology, Center for Cell and Gene Therapy, Baylor College of Medicine, Houston, TX, USA; 20Department of Hematology, Inselspital, Bern University Hospital, Switzerland; 21Markey Cancer Center, University of Kentucky, Lexington, KY, USA; 22Loyola University Medical Center, Maywood, IL, USA; 23University of Kansas Medical Center, Westwood, KS, USA; 24City of Hope Comprehensive Cancer Center, Duarte, CA, USA; 25University of Miami, Miami, FL, USA; 26Division of Blood and Marrow Transplantation, Stanford University, Stanford, CA, USA; 27Division of Hematology and Oncology, Washington University School of Medicine, St. Louis, MO, USA; 28Department of Laboratory Medicine, Karolinska Institutet, Stockholm, Sweden; 29Centre for Clinical Research Sormland, Uppsala University, Uppsala, Sweden; 30Vanderbilt University Medical Center, Nashville, TN, USA; 31Department of Pediatric Hematology, Oncology and Bone Marrow Transplant, British Columbia's Children's Hospital, The University of British Columbia, Vancouver, British Columbia, Canada; 32Department of Medical Oncology and Hematology, CancerCare Manitoba, Winnipeg, Manitoba, Canada; 33Tom Baker Cancer Centre, Calgary, Alberta, Canada; 34Division of Hematology/Oncology, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, USA; 35Department of
Correspondence:
ALEKSANDR LAZARYAN
aleksandr.lazaryan@moffitt.org
Received: March 12, 2019. Accepted: September 20, 2019. Pre-published: September 26, 2019.
doi:10.3324/haematol.2019.220756
Check the online version for the most updated information on this article, online supplements, and information on authorship & disclosures: www.haematologica.org/content/105/5/1329
©2020 Ferrata Storti Foundation
Material published in Haematologica is covered by copyright. All rights are reserved to the Ferrata Storti Foundation. Use of published material is allowed under the following terms and conditions: https://creativecommons.org/licenses/by-nc/4.0/legalcode. Copies of published material are allowed for personal or inter- nal use. Sharing published material for non-commercial pur- poses is subject to the following conditions: https://creativecommons.org/licenses/by-nc/4.0/legalcode, sect. 3. Reproducing and sharing published material for com- mercial purposes is not allowed without permission in writing from the publisher.
haematologica | 2020; 105(5)
1329
ARTICLE